Wedbush Predicts Weaker Earnings for Oruka Therapeutics
Oruka Therapeutics, Inc. (NASDAQ:ORKA – Free Report) – Equities research analysts at Wedbush reduced their Q2 2025 earnings per share estimates for shares of Oruka Therapeutics in a report issued on Wednesday, May 14th. Wedbush analyst D. Nierengarten now expects that the company will post earnings of ($0.46) per share for the quarter, down from […]
Oruka Therapeutics, Inc. (NASDAQ:ORKA – Free Report) – Equities research analysts at Wedbush reduced their Q2 2025 earnings per share estimates for shares of Oruka Therapeutics in a report issued on Wednesday, May 14th. Wedbush analyst D. Nierengarten now expects that the company will post earnings of ($0.46) per share for the quarter, down from […]
